TELLAPRIALBI 與 Liver+AI 使用情況與統計

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery. TELLAPRIALBI allows you to - enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels) - automatically compute APRI, ALBI and APRI+ALBI scores for comparative review - select from a variety of tumor types together with the respective extent of resection and - view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score. The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app. TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.

Apple App Store
免費版
醫療

商店排名

- -

Liver+AI

Terms of Use and Privacy Policy You accept and otherwise agree to be bound by these Terms by downloading or installing the Liver+AI Application, and each time you access or otherwise use the Liver+AI Application thereafter. If you do not accept these Terms, you must not download, install, access, or use the Liver+AI Application. The Data The Liver+AI Application is intended for healthcare professionals participating in a research study using Artificial Intelligence / Machine Learning (AI/ML) to assist in the assessment of donor livers during the organ procurement. The purpose of the Liver+AI Application is to provide a platform for the electronic storage and organization of the liver Information by the Healthcare professionals, and for making the collected Information available to investigate the use of AI/ML to assist the liver transplant team with the evaluation/analysis/assessment of the quality of the liver donor during the organ procurements. Users Participating in the Liver+AI Research Study Only the Healthcare professionals approved will be able to participate in the Liver+AI research study. If you are approved to participate in the Liver+AI research study, we will store your name, and email address needed to sign up in the Liver+AI study. No other personal information about you or your device will be collected. The Liver+AI research information that would be collected by the healthcare professionals participating in the study will include pictures of the livers and description of the livers by the surgeons. Non-traceable data or personally identifiable information from the livers will be collected. No other information not included in the study should be uploaded. The liver images and the data would be stored in a secure cloud service and would be used to analyze the livers by AI/ML. You will only have access to the data you collected and not to the data collected by other healthcare professionals participating in the Liver+AI Research study. You are responsible for allowing access to the Liver+AI data you collected and for all activity that occurs in connection with your Liver+AI Application outside the Liver+AI research study. You can choose to stop using Liver+AI at any time. Contact Us If you have any questions or concerns regarding this Terms of Use / Privacy Policy, please send us an email at Feedback@MedAppsAB.com.